Market Tracker

02/28 7:34am ET

Immunomedics Inc (NASDAQ:IMMU)

5.12
Delayed Data
As of Feb 27
 +0.23 / +4.70%
Today’s Change
1.95
Today|||52-Week Range
5.89
+39.51%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close4.89
Today’s open4.90
Day’s range4.86 - 5.23
Volume2,640,170
Average volume (3 months)2,655,961
Market cap$543.1M
Dividend yield--
Data as of 02/27/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+2.42%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...+0.05+0.40%
ALRPRBAlere Inc-0.02-0.01%
LNTHLantheus Holdings In...-0.05-0.40%
--Quidel Corp-0.20-1.01%
Data as of 02/27/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts